Phase 1 — Disease Origin Discovery
Document Code: SCF-AMC-STRANDSHIFT-HMOA-0001
Program: PROJECT STRANDSHIFT
Classification: Genetic Disease-Origin Investigation
Primary Focus: Origins, Evolution, Amplification, and Biological Consequences of HTT CAG Repeat Expansion
1. EXECUTIVE SUMMARY
The HTT Mutation Origin Analysis investigates the origin, inheritance, molecular evolution, and biological consequences of pathogenic CAG repeat expansion within the Huntingtin (HTT) gene.
Current scientific evidence indicates that Huntington disease originates from inherited expansion of a CAG trinucleotide repeat located within exon 1 of HTT. Disease risk, age of onset, and progression are strongly associated with repeat length and subsequent somatic expansion during life.
PROJECT STRANDSHIFT expands beyond traditional genetic classification by evaluating:
- Germline origins
- Somatic expansion mechanisms
- DNA repair pathway involvement
- Neurodevelopmental modifiers
- Epigenomic influences
- Genome instability amplification
- Neuroimmune convergence
2. HTT GENE ORIGIN PROFILE
Gene Identity
Parameter | Value |
Gene Symbol | HTT |
Full Name | Huntingtin |
Chromosome | 4 |
Cytoband | 4p16.3 |
Primary Mutation | CAG Repeat Expansion |
Protein Product | Huntingtin |
Protein Class | Scaffold Protein |
Inheritance | Autosomal Dominant |
Evolutionary Status
HTT is highly conserved among vertebrates.
Primary Functions:
- Embryonic development
- Vesicular trafficking
- Axonal transport
- Synaptic maintenance
- Transcriptional regulation
- Cellular stress response
Classification:
Essential Developmental Gene
3. PRIMARY MUTATION ORIGIN
Mutation Class
Trinucleotide Repeat Expansion
Sequence:
CAG
Encoded Amino Acid:
Glutamine (Q)
Result:
Polyglutamine Expansion
Origin Mechanism
Current evidence supports repeat-length instability arising through:
- DNA replication slippage
- Repair-associated expansion
- Germline transmission instability
Classification:
Repeat Expansion Mutation
4. HTT CAG CLASSIFICATION SYSTEM
CAG Length | Classification | Expected Outcome |
≤26 | Normal | No disease |
27–35 | Intermediate | Usually unaffected, potential instability in transmission |
36–39 | Reduced penetrance range | Variable disease expression |
≥40 | Full penetrance range | Huntington disease expected |
≥60 | Juvenile-onset risk increases | Early severe disease |
5. GERMLINE ORIGIN ANALYSIS
Inherited Mutation Architecture
Maternal Transmission
Characteristics:
- Relatively stable transmission
- Lower average expansion rate
Potential Outcomes:
- Stable inheritance
- Small expansion events
Paternal Transmission
Characteristics:
- Greater repeat instability
- Increased expansion frequency
Potential Outcomes:
- Anticipation
- Earlier onset in offspring
Classification:
High-Risk Expansion Transmission Pathway
6. GENOMIC INSTABILITY ORIGIN MODEL
Stage 1
Inherited Repeat Expansion
↓
Stage 2
Replication Stress
↓
Stage 3
Repair-System Engagement
↓
Stage 4
Expansion-Prone Repair
↓
Stage 5
Somatic Repeat Growth
↓
Stage 6
Neuronal Toxicity
↓
Stage 7
Clinical Disease
7. DNA REPAIR MODIFIER ORIGIN ANALYSIS
Primary Expansion Drivers
MSH3
Function:
Mismatch repair
Observed Effect:
Promotes repeat expansion
Classification:
Major Expansion Accelerator
MSH2
Function:
Mismatch repair
Contribution:
Expansion-prone repair activity
Classification:
Expansion Facilitator
MLH1
Function:
Mismatch repair signaling
Contribution:
Expansion pathway activation
Classification:
Expansion Modifier
PMS1 / PMS2
Contribution:
Mismatch repair complex function
Classification:
Expansion Modifiers
Protective Modifier
FAN1
Function:
DNA repair and fork protection
Observed Effect:
Suppresses expansion
Classification:
Protective Genetic Modifier
8. SOMATIC EVOLUTION MODEL
Scientific Concept
The inherited mutation is not static.
Expansion continues throughout life.
High-Risk Tissues
Caudate Nucleus
Highest vulnerability
Putamen
High expansion burden
Frontal Cortex
Progressive expansion
Striatal Medium Spiny Neurons
Most vulnerable population
9. RNA ORIGIN CONSEQUENCES
Expanded HTT Transcript
Effects:
- Aberrant RNA processing
- Repeat-associated RNA toxicity
- Altered transcript stability
Classification:
Secondary Molecular Injury Layer
10. PROTEIN ORIGIN CONSEQUENCES
Expanded Polyglutamine Domain
Effects:
- Protein misfolding
- Aggregate formation
- Cellular stress
Classification:
Primary Toxic Gain-of-Function Mechanism
Aggregate Biology
Mutant HTT
↓
Misfolding
↓
Oligomer Formation
↓
Aggregation
↓
Proteostasis Failure
↓
Neuronal Dysfunction
11. NEURODEVELOPMENTAL ORIGIN OVERLAY
Developmental Role of HTT
Normal HTT supports:
- Brain development
- Synaptogenesis
- Axonal guidance
- Cellular survival
Hypothesized Vulnerability Layer
Developmental differences may influence:
- Disease resilience
- Cognitive reserve
- Symptom timing
Classification:
Disease-Modifying Layer
12. NEUROIMMUNE ORIGIN OVERLAY
Mutant HTT Effects
Potential Consequences:
- Microglial activation
- Astrocyte dysfunction
- Cytokine release
Biomarkers:
- IL-6
- TNF-α
- IL-1β
Classification:
Secondary Amplification System
13. VIRAL-RESPONSE ORIGIN OVERLAY
Scientific Assessment
Current evidence does not support HTT mutations evolving into infectious viruses.
PROJECT STRANDSHIFT therefore separates:
HTT Mutation
Inherited genomic alteration
from
Viral Biology
Independent infectious entities
Potential Areas of Investigation
Viral Mimicry
- Interferon signaling
- dsRNA sensing
- cGAS-STING activation
Endogenous Retroelements
- HERV-K
- HERV-W
- LINE-1
Classification:
Genome-Stress Response Layer
14. SCF HTT ORIGIN HIERARCHY
Tier I
Inherited HTT Expansion
Primary Origin
Tier II
DNA Repair Dysregulation
Amplification Origin
Tier III
Somatic Expansion
Progression Origin
Tier IV
RNA Toxicity
Molecular Injury Origin
Tier V
Protein Misfolding
Proteotoxic Origin
Tier VI
Neuroimmune Activation
Inflammatory Origin
Tier VII
Neurodegeneration
Clinical Disease Origin
15. HTT ORIGIN CONVERGENCE MODEL
Inherited HTT Expansion
↓
DNA Repair Interaction
↓
Somatic Expansion
↓
RNA Instability
↓
Protein Misfolding
↓
Mitochondrial Stress
↓
Neuroimmune Activation
↓
Apoptosis
↓
Neurodegeneration
↓
Clinical Huntington Disease
16. CONCLUSIONS
Primary Origin
Inherited HTT CAG repeat expansion.
Expansion Origin
DNA repair-associated repeat instability.
Progression Origin
Somatic expansion and genomic instability.
Molecular Injury Origin
RNA toxicity and mutant huntingtin proteotoxicity.
Amplification Origins
Neuroimmune activation, mitochondrial dysfunction, and cellular stress pathways.
Disease Classification
Huntington disease is best classified as an inherited repeat-expansion neurodegenerative disorder whose pathogenicity is progressively amplified through DNA repair-mediated somatic expansion, RNA dysregulation, protein misfolding, neuroimmune activation, and neuronal loss.
MASTER REGISTRY INDEX
SCF-AMC-STRANDSHIFT-HMOA-0001 — HTT Mutation Origin Analysis
SCF-AMC-STRANDSHIFT-HTT-0001 — HTT Disease Program
SCF-AMC-STRANDSHIFT-EPC-0001 — Etiopathogenic Core Report
SCF-AMC-STRANDSHIFT-GIA-0001 — Genomic Instability Atlas
SCF-AMC-STRANDSHIFT-DRF-0001 — DNA Repair Failure Atlas
SCF-AMC-STRANDSHIFT-SEA-0001 — Somatic Expansion Atlas
SCF-AMC-STRANDSHIFT-NIA-0001 — Neuroimmune Intelligence Atlas
SCF-AMC-STRANDSHIFT-DIA-0001 — DNA Injury Atlas
SCF-AMC-STRANDSHIFT-0001 — PROJECT STRANDSHIFT
SCF-DMRD-MASTER-0001 — SCF Advanced Disease Modeling & Discovery
SCF-PATH-UT-0001 — SCF Pathophysiology Protocol